NEW YORK CITY, NY / ACCESS Newswire / October 5, 2026 / Multiple fungal species, identified through FDA testing in a Neogen Vet product marketed as sterile, drove Neogen Corporation (NASDAQ: NEOG) shares down 7.22%. If you bought NEOG and are now holding a loss, you have legal rights. Shareholders who lost money on Neogen are encouraged to submit their loss information now while the investigation is underway. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

The product at the center of the FDA action is HYCOAT, which Neogen sold under its Neogen Vet brand and which has since been recalled. Published reports linked HYCOAT to nearly 100 affected horses and at least 20 horse deaths. Five separate outlets, including Seeking Alpha, Benzinga, and TipRanks, reported on the FDA warning and the share decline that followed.

Neogen Vet products fall within Neogen's Animal Safety segment, which reported $54.5 million in revenue for the third quarter of fiscal 2026. Neogen's August 21, 2026 proxy statement disclosed a $4.2 million "Other" line item that includes "product recall expenses." Potential fines, litigation costs, and reserves tied to the FDA action have not been quantified. Levi & Korsinsky's investigation concerns potential securities law violations connected to these events.

If the FDA's HYCOAT warning cut into your NEOG holdings, request your free loss evaluation or call Joseph E. Levi, Esq. at (212) 363-7500.

WHY LEVI & KORSINSKY -- Ranked in ISS Securities Class Action Services' Top 50 Report for seven consecutive years, Levi & Korsinsky, LLP is a nationally recognized leader in shareholder rights litigation. With a team of over 70 professionals, the firm has recovered hundreds of millions of dollars for investors.

Frequently Asked Questions About the NEOG Investigation

Q: Who is eligible to participate in the NEOG investigation?
A: Investors who purchased NEOG stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.

Q: How much did NEOG stock drop?
A: Shares fell as over 7% after the FDA issued a warning concerning fungal contamination in the recalled Neogen Vet product HYCOAT. Investors who purchased shares at allegedly inflated prices and suffered losses may be eligible to seek compensation.

Q: What do NEOG investors need to do right now?
A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible to participate in the investigation.

Q: What documents do I need to participate?
A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my NEOG shares -- can I still recover losses?
A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought NEOG and sold at a loss may still participate in the investigation.

Q: What if my NEOG losses are small -- is it still worth contacting a lawyer?
A: Yes. There is no minimum loss amount required to participate in the investigation.

Q: What does it cost me to participate?
A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

SOURCE: Levi & Korsinsky, LLP